Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Yidu Tech, Inc. ( (HK:2158) ) is now available.
Yidu Tech Inc. announced its annual results for the fiscal year ending March 31, 2025, reporting a decline in revenue and gross profit compared to the previous year. Despite the financial losses, the company is at the forefront of the medical AI industry, with its proprietary ‘AI Medical Brain’, YiduCore, making significant technological advancements and achieving full-chain compatibility with high-end chips. Yidu Tech is leading the transition from technical validation to industrial value realization in medical AI, with its solutions being implemented in over 30 leading hospitals, and is poised for substantial growth opportunities as it continues to expand its customer network and strategic partnerships.
The most recent analyst rating on (HK:2158) stock is a Buy with a HK$8.00 price target. To see the full list of analyst forecasts on Yidu Tech, Inc. stock, see the HK:2158 Stock Forecast page.
More about Yidu Tech, Inc.
Yidu Tech Inc. is a leading enterprise in China’s AI healthcare industry, specializing in the integration of artificial intelligence technology with medical needs. The company focuses on creating a full-chain intelligent ecosystem across healthcare, pharmaceuticals, and insurance, leveraging over a decade of experience in medical scenarios and continuous advancements in medical AI technology.
Average Trading Volume: 12,821,778
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.57B
For detailed information about 2158 stock, go to TipRanks’ Stock Analysis page.